Opinion

Video

Type 2 Inflammatory Diseases and Impact on Quality of Life

Panelists discuss how type 2 inflammatory diseases, such as asthma, atopic dermatitis, and chronic rhinosinusitis, can significantly impair patients’ quality of life through persistent symptoms and limitations in daily activities.

  • How do type 2 inflammatory diseases, such as asthma, eosinophilic esophagitis, or chronic rhinosinusitis with nasal polyps, impact patients’ quality of life?
  • What challenges do patients face in managing their type 2 inflammatory disease(s) on a daily basis?
  • Describe type 2 inflammation. What diseases beyond those mentioned above can it be associated with?
  • What causes this overactive inflammatory response? In your clinical practice, how often do you see patients with type 2 inflammation?
Related Videos
Dr Peter Schmid
Susan Perlman, MD, an expert on Friedreich's ataxia
Ana Baramidze, MD, PhD
5 KOLs are featured in this series.
5 KOLs are featured in this series.
This series features 1 KOL.
Related Content
Healthcare concept of professional psychologist doctor consult in psychotherapy session or counsel diagnosis health - Khunatorn - stock.adobe.com.jpeg
September 19th 2024

Cognitive Decline Linked With Premature Death in Schizophrenia

Giuliana Grossi
Results show that cognitive decline, combined with factors like smoking, obesity, and chronic health conditions, sharply increased the likelihood of premature death among patients with schizophrenia.
Managed Care Cast logo
July 18th 2024

Insurance Insights: Dr Jason Shafrin Estimates DMD Insurance Value

Brooke McCormick
On this episode of Managed Care Cast, we're talking with the author of a study published in the July 2024 issue of The American Journal of Managed Care® that estimates the insurance value of novel Duchenne muscular dystrophy (DMD) treatment.
Gene editing | Image Credit: © Degimages - stock.adobe.com
September 18th 2024

Meta-Study Analyzes Immunosuppressive Protocols for AAV Gene Therapy for Monogenic Disorders

Karen Jacobson-Sive
Immunosuppressants used in adeno-associated virus (AAV) gene therapy for monogenic disorders present an adverse effect profile that is consistent with high-dose steroid use in other conditions, according to a meta-study that analyzed immunosuppressive protocols.
Managed Care Cast
May 30th 2024

From Polypharmacy to Personalized Care: Dr Nihar Desai Discusses Holistic Cardiovascular Care

Giuliana Grossi
In this episode of Managed Care Cast, Nihar Desai, MD, MPH, cardiologist and vice chief of Cardiology at the Yale School of Medicine, discusses therapies for cardiovascular conditions as they relate to patient adherence, polypharmacy, and health access.
The authors of the case series noted that prevalent comorbidities among patients with DMD increase the risk of arrhythmias even further. | Image credit: Elena - stock.adobe.com
September 18th 2024

Atrial Arrhythmias Common in DMD, but More Data on Treatment Are Needed

Rose McNulty
Cases of atrial arrhythmia in patients with Duchenne muscular dystrophy (DMD) are common but lack a standard solution, and more long-term data on the management of arrhythmias in DMD are needed.
Diversity animation | Image Credit: annaspoka - stock.adobe.com
September 17th 2024

Dermatologist Dissects Rosacea Diagnosis Challenges Among Patients of Color

Brooke McCormick
Hilary Baldwin, MD, FAAD, highlighted diagnostic complexities and shared treatment strategies for rosacea in patients with darker skin tones at the Skin of Color Update in New York City last Friday.

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

© 2024 MJH Life Sciences® and AJMC®.
All rights reserved.

About
Contact
Editorial Boards
Advertise
Do Not Sell My Information
Terms & Conditions
Privacy Policy
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo